Healthcare spending in the U.S. surged by 7.5% to $4.9 trillion in 2023, with prescription drug use and Affordable Care Act enrollments driving the rise, a government report revealed. The sector accounted for 17.6% of the U.S. economy, reflecting its growing financial impact.
Affordable Care Act Plans Drive Healthcare Spending Surge
According to a research released on Wednesday by the Centers for Medicare and Medicaid Services, private health plan membership, especially those covered by the Affordable Care Act, drove a 7.5% increase in U.S. healthcare spending in 2023, reaching $4.9 trillion, Investing.com shares.
Medicare, the federal program that provides health insurance to those 65 and older or who are disabled, has reported that healthcare spending has surpassed economic growth in the United States. Compared to GDP growth of 2.9% in 2023, it increased by an inflation-adjusted 4.4%, according to the research.
Per a CMS official who spoke at a press event, retail prescription medication spending increased the most, by 11.4% to $449.7 billion, following a 7.8% increase in 2022. This increase was mostly caused by the usage of drugs for diabetes and weight reduction.
Prescription Drug Costs Skyrocket in 2023
According to the official, the amount spent on diabetic medications, including the newer GLP-1 medications like Ozempic and Wegovy, which are also used for weight loss, rose by 35% under the Medicare prescription drug program.
"That significantly contributed to Medicare prescription drug spending growth of 12.2%," according to the official.
In 2023, healthcare accounted up 17.6% of the U.S. economy, a small increase from 17.4% the previous year. The report stated that this percentage is somewhat lower than when the COVID-19 epidemic was at its peak.
In 2023, healthcare spending reached $1.5 trillion, an increase of 10.4 percent, the greatest growth rate in almost 30 years. Clinical service spending went up 7.4 percent.
Commercial Insurers Dominate U.S. Healthcare Costs
The biggest portion of the budget went to commercial insurers, with their share increasing from 19.5% in 2022 to 30% in 2023 as a result of more people enrolling in employer-sponsored health plans and more people enrolling in ACA plans, also known as Obamacare.
Premiums for Obamacare enrollees were lowered by improved subsidies contained in the 2021 American Rescue Plan Act and the 2022 Inflation Reduction Act. More than 2.7% of the population enrolled in an Obamacare plan in 2023, after those policies were introduced.
The CMS states that 3.3 million Americans, or 1.6% of the total population, enrolled in private health insurance in 2023.
Health Insurance Coverage Reaches New High
According to the research, the percentage of Americans with health insurance increased to 92.5% in 2023 from 92.0% in 2022.


RBC Capital: European Medtech Firms Show Minimal Middle East and Energy Risk Exposure
Iran Strikes Oil Tanker Near Dubai Amid U.S. Threats and Ongoing Middle East Conflict
U.S. Stock Futures Surge After WSJ Report on Trump's Iran War Exit Strategy
South Korea's $17.3 Billion Emergency Budget Targets Oil Price Surge
Gold Prices Rebound in Asia Amid Iran War Ceasefire Hopes
Asian Currencies Hold Steady Amid U.S.-Israel-Iran Tensions and BOJ Signals
Oil Prices Surge Amid Middle East Tensions as Houthi Attacks Escalate Conflict
U.S. Treasury Eyes Private Credit Oversight Through Insurance Regulator Talks
Dollar Surges to Nine-Month High as Middle East Tensions Drive Safe-Haven Demand
WTO Ministerial Collapse Leaves Global Digital Trade Rules in Limbo
South Korea March Exports Expected to Surge to Near Five-Year High Amid AI-Driven Chip Demand
Oil Prices Surge to Record Monthly Highs as Middle East War Rattles Global Markets
Canada's Economy Grows Modestly in January 2025, Driven by Energy and Construction
Bank of Korea Nominee Shin Hyun-song Calls for Flexible Monetary Policy Amid Iran War Risks
WTO Digital Trade Moratorium Expires Amid Stalled Negotiations
Aluminum Prices Surge Toward Four-Year Highs After Gulf Smelter Strikes
Goldman Sachs Sees Value in European Real Estate Stocks Despite Sharp Selloff 



